Suchergebnisse - "Jabagi, Marie Joelle"

PubPharm (19)

1

Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines : A Nationwide Self-Controlled Case Series Study

enthalten in: Neurology | 2023

von Le Vu, S. | Bertrand, M. | Botton, J. | +6

2

Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance : A Nationwide Case-Control Study Based on the French National Health Data System

enthalten in: Open forum infectious diseases | 2023

von Semenzato, L. | Botton, J. | Le Vu, S. | +6

3

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster

enthalten in: The New England journal of medicine | 2023

von Jabagi, M. | Bertrand, M. | Botton, J. | +4

4

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France

enthalten in: Annals of internal medicine | 2022

von Botton, J. | Jabagi, M. | Bertrand, M. | +7

5

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule : A cohort study of 28 million people in France

enthalten in: The Lancet regional health. Europe | 2022

von Semenzato, L. | Botton, J. | Drouin, J. | +8

6

Risk of Myocarditis after Covid-19 mRNA Vaccination: Impact of Booster Dose and Dosing Interval

enthalten in: bioRxiv.org | 2022

von Le Vu, S. | Bertrand, M. | Jabagi, M. | +4

7

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

enthalten in: Nature communications | 2022

von Le Vu, S. | Bertrand, M. | Jabagi, M. | +6

8

A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety

enthalten in: Statistics in medicine | 2022

von Ghebremichael-Weldeselassie, Y. | Jabagi, M. | Botton, J. | +7

9

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

enthalten in: JAMA network open | 2022

von Botton, J. | Semenzato, L. | Jabagi, M. | +4

10

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

enthalten in: Vaccine | 2022

von Botton, J. | Dray-Spira, R. | Baricault, B. | +5